TrialClinical rheumatology2019
Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
Minfang Zhang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this paperpooled ittrialcites it